Regulatory Show all
October 23 | 2018

Poster presentation at ESMO 2018 in Munich

Read more
October 23 | 2018

Presentation av poster vid ESMO 2018 i München

Read more
October 9 | 2018

2cureX announces CE-IVD marking of its IndiTreat test

Read more
October 9 | 2018

2cureX meddelar godkänd CE-IVD-märkning av sitt IndiTreat-test

Read more
October 3 | 2018

Add. info to newsletter ”2cureX GmbH receives contribution for the development of IndiTreat® tests in immuno-oncology”

Read more
October 3 | 2018

2cureX tyska dotterbolag erhåller bidrag för utveckling av IndiTreat®-test inom immunonkologi

Read more
September 12 | 2018

Möt oss på Sedermeradagen i Göteborg

Read more
September 12 | 2018

Meet us at Sedermeradagen in Göteborg

Read more
August 22 | 2018

2cureX stärker sin patentportfölj med nytt godkänt europeiskt patent

Read more
August 22 | 2018

2cureX strengthen its patent portfolio with the granting of a new European patent

Read more
July 26 | 2018

Meet us at LSX Nordic Congress

Read more
July 26 | 2018

Möt oss på LSX Nordic Congress

Read more
July 20 | 2018

2cureX continues to update its frequently asked Question page on www.2curex.com

Read more
July 20 | 2018

2cureX fortsätter att uppdatera sin frekvent använda Frågor & Svar-sida på www.2curex.com

Read more
June 21 | 2018

2cureX presenterar positiva kliniska data från den kliniska studien med IndiTreat vid ESMO i Barcelona

Read more
June 21 | 2018

2cureX presents positive clinical data from its IndiTreat® CRC trial at ESMO in Barcelona

Read more